Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix booster immunogenicity and safety study in healthy Russian subjects aged 4 years and older
2015-003405-42Phase 3
- Sponsor
- GSK
- Start
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of acellular pertussis vaccine in diphtheria, Tetanus and pertussis, sponsored by GSK. Primary endpoint: Number of seroprotected subjects for anti-diphtheria and anti-tetanus.
02
Drugs
acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2015-003405-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003405-42.